
    
      This is a study to evaluate safety, tolerability and pharmacokinetics of a long-acting
      injectable NNRTI VM-1500A-LAI single and multiple ascending doses in healthy subjects. The
      study will be conducted in 1 investigational site in Russia in healthy volunteers.
    
  